Kanesa-thasan Niranjan's Form 4 filing
Icosavax, Inc. (ICVX) · filed Jan 5, 2024
- Accession no.
- 0001209191-24-001074
- Filed
- Jan 5, 2024
- Trade date
- Jan 4, 2023
- Filing delay
- 366 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.67M. It was filed 366 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kanesa-thasan NiranjanCIK 0001874021 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | Common Stock | MOption exerciseAcquired | +13,806 | $0.84 | +$11,597.04 | 237,786 | Direct | |
| Jan 4, 2023 | Common Stock | MOption exerciseAcquired | +74,648 | $1.04 | +$77,633.92 | 312,434 | Direct | |
| Jan 4, 2023 | Common Stock | MOption exerciseAcquired | +11,947 | $5.90 | +$70,487.3 | 324,381 | Direct | |
| Jan 4, 2023 | Common Stock | MOption exerciseAcquired | +5,972 | $15.00 | +$89,580 | 330,353 | Direct | |
| Jan 4, 2023 | Common Stock | SSaleDisposed | −106,373 | $15.70 | −$1,670,056.1 | 223,980 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | Common Stock | MOption exerciseDisposed | −13,806 | $0.00 | $0 | 2,511 | Direct | |
| Jan 4, 2023 | Common Stock | MOption exerciseDisposed | −74,648 | $0.00 | $0 | 42,193 | Direct | |
| Jan 4, 2023 | Common Stock | MOption exerciseDisposed | −11,947 | $0.00 | $0 | 108,369 | Direct | |
| Jan 4, 2023 | Common Stock | MOption exerciseDisposed | −5,972 | $0.00 | $0 | 118,528 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.